Lin, Weiying, Zhuoyi Lin, and Mengxue Zhang. 2022. “The Therapy of Osimertinib for EGFR Mutation—Non-Small Cell Lung Cancer”. Highlights in Science, Engineering and Technology 6 (July): 219-29. https://doi.org/10.54097/hset.v6i.964.